The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Mechanisms of Human Hepatocarcinogenesis
Abstract
The major risk factors and etiological agents responsible for development of hepatocellular carcinoma in humans have been identified and characterized. Among these are chronic infection with hepatitis B virus or hepatitis C virus, exposure to aflatoxin B1, and cirrhosis of any etiology (including alcoholic cirrhosis and cirrhosis associated with genetic liver diseases). Both chronic hepatitis and cirrhosis represent major preneoplastic conditions of the liver as the majority of hepatocellular carcinomas arise in these pathological settings. Hepatocarcinogenesis represents a linear and progressive process in which successively more aberrant monoclonal populations of hepatocytes evolve. Regenerative hepatocytes in focal lesions in the inflamed liver (chronic hepatitis or cirrhosis) give rise to hyperplastic hepatocyte nodules, and these progress to dysplastic nodules, which are thought to be the direct precursor of hepatocellular carcinoma. In most cases, the neoplastic transformation of hepatocytes results from accumulation of genetic damage during the repetitive cellular proliferation that occurs in the injured liver in response to paracrine growth factor and cytokine stimulation. Hepatocellular carcinomas exhibit numerous genetic abnormalities (including chromosomal deletions, rearrangements, aneuploidy, gene amplifications, and mutations), as well as epigenetic alterations (including modulation of DNA methylation). These genetic and epigenetic alterations combine to activate positive mediators of cellular proliferation (including cellular proto-oncogenes and their mitogenic signaling pathways) and inactivate negative mediators of cellular proliferation (including tumor suppressor genes), resulting in cells with autonomous growth potential. However, hepatocellular carcinomas exhibit a high degree of genetic heterogeneity, suggesting that multiple molecular pathways may be involved in the genesis of subsets of hepatocellular neoplasms. Continued investigation of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in liver, enabling the development of effective strategies for prevention and/or more effective treatment of hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Primary Carcinoma of The Liver
Berman, C. L. (1958) · Advances in cancer research · doi:10.1016/s0065-230x(08)60409-1 · Cited by 392
[Epidemiology of hepatocellular carcinoma].
Rosellini, S. R., & Miglio, F. (1991) · PubMed · Cited by 326
GNASSI, A. M. (1941) · The American Journal of Surgery · doi:10.1016/s0002-9610(41)90296-9 · Cited by 49
Alcohol, Hepatotropic Viruses, and Hepatocellular Carcinoma
Nalpas, B., Feitelson, M. A., Bréchot, C., et al. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01585.x · Cited by 21
The Role of Genomic Instability in the Development of Human Cancer
Coleman, W. B., & Tsongalis, G. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_6 · Cited by 14
Self-citationStructural alterations in c-myc and c-Ha-ras proto-oncogenes in human hepatocellular carcinoma.
Fukuda, K., Ogasawara, S., Maruiwa, M., Yano, H., Murakami, T., & Kojiro, M. (1988) · The Kurume Medical Journal · doi:10.2739/kurumemedj.35.77 · Cited by 7
Inactivation of Negative Growth Regulators During Neoplastic Transformation
Smolinski, K. N., & Meltzer, S. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_5 · Cited by 2
Cited by
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Choi, J.-Y., Lee, J.-M., & Sirlin, C. B. (2014) · Radiology · doi:10.1148/radiol.14132361 · Cited by 513
Ringe, K. I., Husarik, D. B., Sirlin, C. B., & Merkle, E. M. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4392 · Cited by 388
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
NELSON, W. G., DE MARZO, A. M., DeWEESE, T. L., & ISAACS, W. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142058.99614.ff · Cited by 386
Metadata
- Authors
- Coleman, W. B.
- Venue
- Current Molecular Medicine
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-09-01
- Volume
- 3
- Issue
- 6
- Pages
- 573-588
- ISSN
- 1566-5240 (ISSN-L)
- 0000-0000
- OpenAlex
- W1973253290
- Cited by
- 256
- References
- 10
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Human Hepatocarcinogenesis. https://app.cochat.ai/papers/10.2174/1566524033479546
- The paper
- Coleman, W. B. (2003). Mechanisms of Human Hepatocarcinogenesis. Current Molecular Medicine. https://doi.org/10.2174/1566524033479546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.